Search

CryoPort Inc

Suletud

SektorTööstus

15.64 -1.26

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

15.6

Max

16.46

Põhinäitajad

By Trading Economics

Sissetulek

14M

-9.4M

Müük

2.3M

48M

Aktsiakasum

-0.19

Kasumimarginaal

-19.733

Töötajad

684

EBITDA

1.2M

-2.5M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

-5.6% downside

Dividendid

By Acuity

Järgmine tulemuste avaldamine

4. aug 2026

Turustatistika

By TradingEconomics

Turukapital

294M

815M

Eelmine avamishind

16.9

Eelmine sulgemishind

15.64

Uudiste sentiment

By Acuity

34%

66%

125 / 403 Pingereas Industrials

CryoPort Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

20. juuli 2026, 21:01 UTC

Cryoport Inc shares are lower in after-market hours, reflecting broader economic concerns following a decline in the Conference Board's Leading Economic Index for June.

Võrdlus sarnastega

Hinnamuutus

CryoPort Inc Prognoos

Hinnasiht

By TipRanks

-5.6% langus

12 kuu keskmine prognoos

Keskmine 14.83 USD  -5.6%

Kõrge 17 USD

Madal 12 USD

Põhineb 7 Wall Streeti analüütiku instrumendi CryoPort Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

7 ratings

6

Osta

1

Hoia

0

Müü

Sentiment

By Acuity

125 / 403 Pingereas Tööstus

Uudiste sentiment

Languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest CryoPort Inc

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing services. In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C; Cryoport Cryoshuttle provides clients with dedicated local transportation support; and Tec4Med. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.
help-icon Live chat